0001209191-22-022524.txt : 20220404
0001209191-22-022524.hdr.sgml : 20220404
20220404170854
ACCESSION NUMBER: 0001209191-22-022524
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220331
FILED AS OF DATE: 20220404
DATE AS OF CHANGE: 20220404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Combs Andrew
CENTRAL INDEX KEY: 0001825005
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39527
FILM NUMBER: 22803602
MAIL ADDRESS:
STREET 1: C/O PRELUDE THERAPEUTICS INCORPORATED
STREET 2: 200 POWDER MILL ROAD
CITY: WILMINGTON
STATE: DE
ZIP: 19803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Prelude Therapeutics Inc
CENTRAL INDEX KEY: 0001678660
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811384762
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 POWDER MILL ROAD
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: (302) 547-3768
MAIL ADDRESS:
STREET 1: 200 POWDER MILL ROAD
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: Prelude Therapeutics Inc.
DATE OF NAME CHANGE: 20160630
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-31
0
0001678660
Prelude Therapeutics Inc
PRLD
0001825005
Combs Andrew
C/O PRELUDE THERAPEUTICS INCORPORATED
200 POWDER MILL ROAD
WILMINGTON
DE
19803
0
1
0
0
EVP, Head of Chemistry
Common Stock
2022-03-31
4
M
0
36062
1.89
A
304442
D
Employee Stock Option (right to buy)
1.89
2022-04-01
4
M
0
36062
0.00
D
2030-03-26
Common Stock
36062
50397
D
Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met.
The stock option vested as to 25% of the total shares on March 6, 2021, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ Laurent Chardonnet, as Attorney-in-Fact
2022-04-04